CH624093A5 - Process for the preparation of biologically active polypeptides - Google Patents

Process for the preparation of biologically active polypeptides Download PDF

Info

Publication number
CH624093A5
CH624093A5 CH409276A CH409276A CH624093A5 CH 624093 A5 CH624093 A5 CH 624093A5 CH 409276 A CH409276 A CH 409276A CH 409276 A CH409276 A CH 409276A CH 624093 A5 CH624093 A5 CH 624093A5
Authority
CH
Switzerland
Prior art keywords
polypeptide
asp
ige
ser
pro
Prior art date
Application number
CH409276A
Other languages
German (de)
English (en)
Inventor
Robert Newfield Hamburger
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762602443 external-priority patent/DE2602443A1/de
Application filed by Univ California filed Critical Univ California
Publication of CH624093A5 publication Critical patent/CH624093A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH409276A 1975-04-04 1976-04-01 Process for the preparation of biologically active polypeptides CH624093A5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56542575A 1975-04-04 1975-04-04
DE19762602443 DE2602443A1 (de) 1975-04-04 1976-01-23 Biologisch aktive polypeptide

Publications (1)

Publication Number Publication Date
CH624093A5 true CH624093A5 (en) 1981-07-15

Family

ID=25769954

Family Applications (1)

Application Number Title Priority Date Filing Date
CH409276A CH624093A5 (en) 1975-04-04 1976-04-01 Process for the preparation of biologically active polypeptides

Country Status (8)

Country Link
AU (1) AU514308B2 (xx)
CA (1) CA1087171A (xx)
CH (1) CH624093A5 (xx)
FR (1) FR2305989A1 (xx)
GB (1) GB1539102A (xx)
MX (1) MX3790E (xx)
NL (1) NL7603384A (xx)
SE (1) SE430058B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
SI2162133T1 (sl) * 2007-07-09 2016-11-30 Nestec S.A. Postopki za zmanjšanje alergij, ki jih povzročajo alergeni iz okolja
US11912785B2 (en) 2017-12-06 2024-02-27 Steven W. Bailey Peptide compositions for slowing degradation of vitamin mineral supplements, foods, pharmaceutical and cosmetics

Also Published As

Publication number Publication date
CA1087171A (en) 1980-10-07
FR2305989B1 (xx) 1979-10-05
AU1230376A (en) 1977-09-29
AU514308B2 (en) 1981-02-05
NL7603384A (nl) 1976-10-06
SE7603897L (sv) 1976-10-05
FR2305989A1 (fr) 1976-10-29
SE430058B (sv) 1983-10-17
GB1539102A (en) 1979-01-24
MX3790E (es) 1981-07-20

Similar Documents

Publication Publication Date Title
DE2602443C2 (xx)
US4171299A (en) Polypeptide agents for blocking the human allergic response
DE69216150T2 (de) Tachykininderivate, deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2617646C2 (de) Nonapeptid-amide und Decapeptid-amide mit Gonadoliberin-Wirkung, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE2509783C2 (de) Decapeptidamide und Verfahren zu deren Herstellung
DE2321174C2 (de) Nonapeptidamid und Verfahren zu ihrer Herstellung
DE68923401T2 (de) Peptide mit T-Zellen-Helfer-Wirksamkeit.
CH644352A5 (en) Process for the preparation of peptides
DE3782010T2 (de) Vom calcitonin-gen abgeleitete peptidderivate.
DE69219590T2 (de) BPC-Peptide, deren Herstellung und Verwendung
DE2822951A1 (de) Neue polypeptide mit thymusaktivitaet oder antagonistischer aktivitaet und verfahren zu ihrer herstellung
DD200799A5 (de) Verfahren zur herstellung von peptiden
DE2544348A1 (de) L-leucin-13-motilin, verfahren zu dessen herstellung und dasselbe enthaltendes mittel
DE69425212T2 (de) Dem Motilin ähnliche Polypeptide mit stimulierender Wirkung auf den gastrointestinalen Trakt
DE68906066T2 (de) Peptid und dessen salze und antiallergische peptidmittel, welche diese peptide enthalten.
DE69315849T2 (de) Peptide als lungensurfactant und therapeutisch wirksame mischungen
DE69018914T2 (de) Pharmakologisch aktive Präparate und sie enthaltende Arzneimittel.
DE69301468T2 (de) Peptide mit Bradykinin-antagonistischer Wirkung
CH624093A5 (en) Process for the preparation of biologically active polypeptides
DE2633976A1 (de) Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE69511259T2 (de) N-amidino- dermorphin-derivat
EP0003028B1 (de) Beta h-Endorphin-Analoge, diese enthaltende Präparate und deren Herstellung
US4016259A (en) Contraceptive polypeptides
DE3782006T2 (de) Peptide.
DE69304155T2 (de) Neue Peptid-Derivate mit Bradikyninantagonischer Wirkung, Verfahren zur deren Herstellung und pharmazeutische Zubereitungen die sie enthalten

Legal Events

Date Code Title Description
PL Patent ceased